Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
INDUSTRY
×
Lymphatic Abnormalities
×
Clear all
Filters
3
NCT05948943
2026-02-13
EPIK-L1
Novartis
Phase 2/3
Recruiting
232 enrolled
NCT06239480
2025-07-23
SELVA
Palvella Therapeutics, Inc.
Phase 3
Recruiting
40 enrolled